Moderna’s current price is less than $20 below the psychologically significant $50 price level. Traders often focus on these round-numbered levels as support and resistance points for a stock. Traders should expect that Moderna will see another surge in buying if the stock remains above $50 for more than two trading sessions.

HHS Allocates $590 Million to Speed Up the Development of mRNA Vaccines for Pandemic Influenza, Including an H5N1 (Bird Flu) Vaccine

CAMBRIDGE, MA / ACCESS Newswire / January 17, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines.

The US Department of Health and Human Services has decided to spend nearly $600 million on the development of a bird flu vaccine.According to CNN, HSS on Friday, January 17, 2025, announced that it will award $590 million to Moderna to resume

US health officials announced Friday they were awarding $590 million to Moderna to develop mRNA vaccines against influenza, including advancing the company's bird flu vaccine, as fears of a new pandemic grow.

With cases of avian influenza A(H5N1) continuing to rise among cattle and humans in the US, scientists and government health officials are preparing for the potential of the virus adapting to enable human-to-human transmission.

Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of

Funding will also support the expansion of clinical studies for up to five additional subtypes of pandemic influenza

The risk to the general public from bird flu is low, and there has been no further evidence of person to person spread, according to the U.S. Centers for Disease Control and Prevention.

The public health risk remains low, but bird flu variants have proven to be unpredictable, which is why the virus is a top priority for the federal government.

Georgia officials halted all in-state poultry sales, and the U.S. Department of Health and Human Services awarded $590 million to Moderna to develop vaccines to protect people from flu strains in bird